These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38981746)

  • 1. Predicting the response to neoadjuvant chemoradiation for rectal cancer using nomograms based on MRI tumour regression grade.
    Qin S; Chen Y; Liu K; Li Y; Zhou Y; Zhao W; Xin P; Wang Q; Lu S; Wang H; Lang N
    Cancer Radiother; 2024 Aug; 28(4):341-353. PubMed ID: 38981746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of pathological response and lymph node metastasis after neoadjuvant therapy in rectal cancer through tumor and mesorectal MRI radiomic features.
    Qin S; Liu K; Chen Y; Zhou Y; Zhao W; Yan R; Xin P; Zhu Y; Wang H; Lang N
    Sci Rep; 2024 Sep; 14(1):21927. PubMed ID: 39304726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer.
    Ren DL; Li J; Yu HC; Peng SY; Lin WD; Wang XL; Ghoorun RA; Luo YX
    World J Gastroenterol; 2019 Jan; 25(1):118-137. PubMed ID: 30643363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Wan L; Zhang C; Zhao Q; Meng Y; Zou S; Yang Y; Liu Y; Jiang J; Ye F; Ouyang H; Zhao X; Zhang H
    Abdom Radiol (NY); 2019 Sep; 44(9):2978-2987. PubMed ID: 31327039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
    Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of an MRI-based radiomic nomogram to distinguish between good and poor responders in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
    Wang J; Liu X; Hu B; Gao Y; Chen J; Li J
    Abdom Radiol (NY); 2021 May; 46(5):1805-1815. PubMed ID: 33151359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
    World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting poor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer: Model constructed using pre-treatment MRI features of structured report template.
    Tang X; Jiang W; Li H; Xie F; Dong A; Liu L; Li L
    Radiother Oncol; 2020 Jul; 148():97-106. PubMed ID: 32339781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 10. Predicting Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Using Deep Learning of Diffusion Kurtosis MRI.
    Zhang XY; Wang L; Zhu HT; Li ZW; Ye M; Li XT; Shi YJ; Zhu HC; Sun YS
    Radiology; 2020 Jul; 296(1):56-64. PubMed ID: 32315264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].
    Zhang XY; Zhu HT; Li XT; Li YJ; Li ZW; Wang WH; Wu AW; Sun YS; Zhang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):228-234. PubMed ID: 35340172
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study.
    Shaish H; Aukerman A; Vanguri R; Spinelli A; Armenta P; Jambawalikar S; Makkar J; Bentley-Hibbert S; Del Portillo A; Kiran R; Monti L; Bonifacio C; Kirienko M; Gardner KL; Schwartz L; Keller D
    Eur Radiol; 2020 Nov; 30(11):6263-6273. PubMed ID: 32500192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nomogram for predicting the overall survival in rectal cancer patients after total neoadjuvant therapy.
    Liu Z; He M; Wang X
    Tech Coloproctol; 2024 Aug; 28(1):107. PubMed ID: 39141173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dynamic nomogram for predicting pathologic complete response to neoadjuvant chemotherapy in locally advanced rectal cancer.
    Wang G; Li J; Huang Y; Guo Y
    Cancer Med; 2024 Jun; 13(11):e7251. PubMed ID: 38819440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Longitudinal MRI-Based Artificial Intelligence System to Predict Pathological Complete Response After Neoadjuvant Therapy in Rectal Cancer: A Multicenter Validation Study.
    Ke J; Jin C; Tang J; Cao H; He S; Ding P; Jiang X; Zhao H; Cao W; Meng X; Gao F; Lan P; Li R; Wu X
    Dis Colon Rectum; 2023 Dec; 66(12):e1195-e1206. PubMed ID: 37682775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
    Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative analysis of diffusion weighted imaging to predict pathological good response to neoadjuvant chemoradiation for locally advanced rectal cancer.
    Tang Z; Zhang XY; Liu Z; Li XT; Shi YJ; Wang S; Fang M; Shen C; Dong E; Sun YS; Tian J
    Radiother Oncol; 2019 Mar; 132():100-108. PubMed ID: 30825957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and multicenter validation of a multiparametric imaging model to predict treatment response in rectal cancer.
    Schurink NW; van Kranen SR; van Griethuysen JJM; Roberti S; Snaebjornsson P; Bakers FCH; de Bie SH; Bosma GPT; Cappendijk VC; Geenen RWF; Neijenhuis PA; Peterson GM; Veeken CJ; Vliegen RFA; Peters FP; Bogveradze N; El Khababi N; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ
    Eur Radiol; 2023 Dec; 33(12):8889-8898. PubMed ID: 37452176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT-based delta-radiomics nomogram to predict pathological complete response after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma patients.
    Fan L; Yang Z; Chang M; Chen Z; Wen Q
    J Transl Med; 2024 Jun; 22(1):579. PubMed ID: 38890720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.